Page 8 - ஆன்டிபாடி காக்டெய்ல் பயன்படுத்தப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆன்டிபாடி காக்டெய்ல் பயன்படுத்தப்பட்டது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆன்டிபாடி காக்டெய்ல் பயன்படுத்தப்பட்டது Today - Breaking & Trending Today

Monoclonal antibody therapy successful sir ganga ram hospital delhi patient discharged within 12 hours


URL copied
Image Source : PTI
Monoclonal antibody successfully used in 2 patients at Sir Ganga Ram hospital; one discharged within 12 hrs
The monoclonal antibody therapy was successfully used in two patients at Delhi-based Sir Ganga Ram hospital. The hospital is administering a combination of casirivimab and imdevimab to consenting patients with mild and moderate COVID-19 symptoms at high risk of developing serious illness. 
According to a statement released by the hospital, the therapy was used in two patients with fast progression of symptoms within first seven days and it has changed the outcome .
The hospital said that a 36-year-old healthcare worker who was down with high-grade fever, cough, myalgia, severe weakness and leucopenia was administered REGCov2 on day 6 of the disease. Patient s parameter improved within 12 hours and was discharged, it said.  ....

Pooja Khosla , Ganga Ram , Department Of Medicine , Image Source , Sir Ganga Ram , Delhi Based Sir Ganga Ram , Senior Consultant , Sir Ganga Ram Hospital , பூஜா கோசில , கங்கா ரேம் , துறை ஆஃப் மருந்து , படம் மூல , ஐயா கங்கா ரேம் , மூத்தவர் ஆலோசகர் , ஐயா கங்கா ரேம் மருத்துவமனை ,

Welcome To IANS Live - NATION - Seropositivity rate, anti-spike antibody titre higher in Covishield than Covaxin: Study

The study is titled, Antibody Response after Second-dose of ChAdOx1-nCOV (CovishieldTM) and BBV-152 (CovaxinTM) among Health Care Workers in India: Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study published in MedRxiv.The ....

New Delhi , Dakul Seth , News Service , India Private , All Rights , புதியது டெல்ஹி , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் , தடுப்பு மருந்துகள் ,

Welcome To IANS Live - LatestNews - Seropositivity rate, anti-spike antibody titre higher in Covishield than Covaxin: Study

The study is titled, Antibody Response after Second-dose of ChAdOx1-nCOV (CovishieldTM) and BBV-152 (CovaxinTM) among Health Care Workers in India: Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study published in MedRxiv.The ....

New Delhi , Dakul Seth , News Service , India Private , All Rights , புதியது டெல்ஹி , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் , தடுப்பு மருந்துகள் ,

People who received Pfizer-Biontech vaccine have lower antibody levels targeting the delta variant

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet. ....

United Kingdom , Oxford Astrazeneca , Biontech Covid , Africa Beta , Emily Henderson , Senior Clinical Research Fellow For The Legacy , Kingdom National Virology Consortium , Committee On Vaccination , National Virology Consortium , Foundation Trust , University College London Hospitals , National Institute For Health Research , Virus Threats Advisory Group , Virus Replication Laboratory , Biomedical Research Centre , Francis Crick Institute , National Institute , Health Research , Research Centre , Emerging Respiratory Virus Threats Advisory Group , Joint Committee , South Africa , Senior Clinical Research Fellow , Replication Laboratory , United Kingdom National Virology Consortium , Ars Cov 2 ,